An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial-Reference-Cited by-同舟云学术

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

Published:2008-07 Issue:9633 Volume:372 Page:145-154
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Wood Christopher,Srivastava Pramod,Bukowski Ronald,Lacombe Louis,Gorelov Andrei I,Gorelov Sergei,Mulders Peter,Zielinski Henryk,Hoos Axel,Teofilovici Florentina,Isakov Leah,Flanigan Robert,Figlin Robert,Gupta Renu,Escudier Bernard

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0;Ferlay,2004

2. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

3. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria;Tsui;J Urol,2000

4. Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized study;Pizzocaro;J Clin Oncol,2001

5. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors;Giuliani;J Urol,1990

Cited by 293 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine Resistant Triple Negative Breast Tumor Derived Mesoporous Silicon Nanovaccine Overcame Drug Resistance;Advanced Functional Materials;2024-09-13

2. Cancer neoepitopes viewed through negative selection and peripheral tolerance: a new path to cancer vaccines;Journal of Clinical Investigation;2024-03-01

3. Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy;Molecular Biology Reports;2024-01-28

4. Recent advancements in cancer vaccines: A systematic review;Vacunas (English Edition);2024-01

5. Adjuvant therapy for renal cell carcinoma: A systematic review of current landscape and future directions;Critical Reviews in Oncology/Hematology;2023-12